Iron deficiency in Russia: main problems and possible solutions


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper reviews the current epidemiological problems of iron deficiency and anemia in Russia. The authors place emphasis on women of reproductive age and pregnant women who represent the most socially signif icant group of the population. Morbidity rates and population characteristics of the problem are presented in detail. The paper examines the signif icance of global medical and social issues and the consequences of iron def iciency, issues related to the quality of life, clinical manifestations, the impact on reproductive function and the consequences of pregnancy. The authors give a detailed description of the modern understanding of iron metabolism, its regulation, mechanisms of absorption and transportation, and possible schemes for the development of iron deficiency. The authors explain the role of such iron regulatory proteins as divalent metallotransporter, ferroportin, hepcidin and their interaction, the values of other metals involved in iron metabolism, such as copper and manganese. The pathogenetic aspects of sideropenic and anemic syndromes, their significance in reproductive function and fetal formation are considered in detail. Both classical and novel algorithms and approaches are given. The paper presents modern algorithms for the treatment of latent iron deficiency and iron deficiency anemia, possible approaches and recommendations of various medical specialists. This paper attempts to show the most effective medications and approaches to their use in women with iron deficiency anemia. The advantages of liquid medications are described; the most effective doses, regimens, and duration of their use are discussed. As a result, the authors summarize all the information, present the simplest schemes for the diagnosis and treatment of different stages of iron def iciency and suggest a new approach to the treatment of iron def iciency, using the previous solution of the problem. Conclusion: Iron deficiency remains a serious problem in Russia. However, there is a possibility that incidence of iron deficiency will be reduced in our country in the near future.

Full Text

Restricted Access

About the authors

Nikolay I. Stuklov

Peoples' Friendship University of Russia; National Medical Research Radiological Center, Ministry of Health of the Russian Federation

Email: stuklovn@gmail.com
Dr. Med. Sci., Professor at the Department of Hospital Therapy with Courses of Endocrinology, Hematology and Clinical Laboratory Diagnostics, Medical Institute

Irakli G. Basiladze

Peoples' Friendship University of Russia; A.S. Loginov Moscow Clinical Scientific Center, Moscow Health Department

doctor-hematologist, Department of Hematology

Nikolay D. Kisly

Peoples' Friendship University of Russia

Dr. Med. Sci., Professor, Department of Hospital Therapy with Courses of Endocrinology, Hematology and Clinical Laboratory Diagnostics, Medical Institute

References

  1. World Health Organization. The World Health Report 2002: reducing risks, promoting healthy life. Geneva: WHO; 2002. 236p.
  2. WHO/NHD/01.3. World Health Organization. Iron deficiency anaemia. Assessment, prevention, and control. A guide for programme managers. Geneva: WHO; 2001. 132p.
  3. Резолюция совета экспертов по железодефицитной анемии у женщин. Акушерство и гинекология. Новости. Мнения. Обучение. 2020; 8(4): 28-36. https://dx.doi.org/10.24411/2303-9698-2020-14004.
  4. Beard J.L. Iron requirements in adolescent females. J. Nutr. 2000; 130(2S Suppl.): 440S-2S. https://dx.doi.org/10.1093/jn/130.2.440S.
  5. WHO. Food and Agriculture Organization of the United Nation. Human vitamin and mineral requirements. Report of a joint FAO/WHO expert consultation, Bangkok, Thailand. Food and Nutrition Division FAO Rome; 2001. 303p.
  6. Fairweather-Tait S. Iron requirements and prevalence of iron deficiency in adolescents. An overview. In: Hallberg L., Asp N.G., eds. Iron nutrition in heath and disease. John Libbey and Co. Ltd.; 1996: 137-48.
  7. Abbaspour N., Hurrell R., Kelishadi R. Review on iron and its importance for human health. J. Res. Med. Sci. 2014; 19(2): 164-74.
  8. Демихов В.Г., Морщакова Е.Ф., Румянцев А.Г. Патогенез и лечение анемии беременных. М.: Практическая медицина; 2015. 224с.
  9. Стуклов Н.И., Козинец Г.И., Тюрина Н.Г. Учебник по гематологии. М.: Практическая медицина; 2018. 336с.
  10. Стуклов Н.И. Железодефицитная анемия в практике гинеколога. Алгоритмы диагностики, профилактики и лечения. Акушерство и гинекология. 2016; 7: 99-104. http://dx.doi.org/10.18565/aig.2016.7.99-104.
  11. Шилов А.М. Хроническая сердечная недостаточность и железодефицитная анемия в практике врача первичного звена здравоохранения. Лечебное дело. 2013; 3: 8-16.
  12. Стуклов Н.И. Дефицит железа и анемия у больных хронической сердечной недостаточностью. Рациональная фармакотерапия в кардиологии. 2017; 13(5): 651-60. https://dx.doi.org/10.20996/1819-6446-2017-13-5-651-660.
  13. Дикке Г.Б., Стуклов Н.И. Латентный дефицит железа и железодефицитная анемия у беременных. Алгоритмы диагностики и лечения. Фарматека. 2021; 28(6): 19-24. https://dx.doi.org/10.18565/pharmateca.2021.6.00-00.
  14. Means R.T. Iron deficiency and iron deficiency anemia: implications and impact in pregnancy, fetal development, and early childhood parameters. Nutrients. 2020; 12(2): 447. https://dx.doi.org/10.3390/nu12020447.
  15. Blot L., Diallo D., Tchernia G. Iron deficiency in pregnancy: effects of the newborn. Curr. Opin. Hematol. 1999; 6(2): 65-70. https://dx.doi.org/10.1097/00062752-199903000-00002.
  16. Лебедев В.В., Демихов В.Г., Дмитриев А.В., Аиари М., Фомина М.А. Сравнительная эффективность и безопасность применения препаратов двух- и трехвалентного железа для лечения железодефицитной анемии. Вопросы гематологии/онкологии и иммунопатологии в педиатрии. 2016; 15(4): 5-12. https://dx.doi.org/10.24287/1726-1708-2016-15-4-5-12.
  17. Dallalio G., Law E., Means R.T. Jr. Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations. Blood. 2006; 107(7): 2702-4. https://dx.doi.org/10.1182/blood-2005-07-2854.
  18. Сахин В.Т., Маджанова Е.Р., Крюков Е.В., Казаков С.П., Рукавицын О.А. Анемия хронических заболеваний: особенности патогенеза и возможности терапевтической коррекции (обзор литературы и результаты собственных исследований). Онкогематология. 2018; 13(1): 45-53. https://dx.doi.org/10.17650/1818-8346-2018-13-1-45-53.
  19. Кирилюк А.А. Железосодержащие лекарственные средства: от клинической фармакологии до фармацевтической помощи (Сообщение 1). Вестник фармации. 2020; 3: 81-97.
  20. Jacobs P., Johnson G., Wool L. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose. J. Med. 1984; 15(5-6): 367-77.
  21. Ребров В.Г., Егорова Е.Ю., Громова О.А., Торшин И.Ю. Парадокс лечения анемий: когда меньшее становится лучшим. Эффективная фармакотерапия. 2010; 3: 26-8.
  22. Семенова Е., Кунина М., Стуклов Н. Роль меди и марганца в метаболизме железа. Врач. 2013; 12: 47-52.
  23. Логутова Л.С. Анемия у беременных: вопросы этиологии, диагностики и лечения. РМЖ. Мать и дитя. 2016; 5: 290-3.
  24. Pizarro F., Yip R., Dallman P.R., Olivares M., Hertrampf E., Walter T. Iron status with different infant regimens: relevance to screening and prevention of iron deficiency. J. Pediatr. 1991; 118(5): 687-92. https://dx.doi.org/10.1016/s0022-3476(05)80027-7.
  25. WHO. WHO guideline on use of ferritin concentrations to assess iron status in individuals and populations. Geneva: World Health Organization; 2020. 72р.
  26. WHO. Guideline: daily iron supplementation in adult women and adolescent girls. Geneva: World Health Organization; 2016.
  27. Gillespie S.R., Kevany J., Mason J.B., eds. United Nations. Administrative Committee on Coordination. Subcommittee on Nutrition. Controlling iron deficiency: a report based on an ACC/SCN Workshop. United Nations, Administrative Committee on Coordination/Subcommittee on Nutrition; 1991. 93p.
  28. Стуклов Н.И., Леваков С.А., Сушинская Т.В., Митченкова А.А., Ковальчук М.О. Профилактика и лечение анемии у женщин репродуктивного возраста при гинекологических заболеваниях. Акушерство и гинекология. 2020; 3: 218-26. https://dx.doi.org/10.18565/aig.2020.3.218-226.
  29. Data, WHO. Guideline: intermittent iron and folic acid supplementation in menstruating women. Geneva: World Health Organization; 2011.
  30. DeMaeyer Е.М., Dallman Р., Gurney J.M., Hallberg L., Sood S.K., Srikantia S.G. Preventing and controlling iron deficiency anaemia through primary health care. А guide for health administrators and programme managers. Geneva: World Неаlth Organization; 1989. 61p.
  31. Кунина М.Ю., Семенова Е.Н., Стуклов Н.И. Особенности ответа на терапию железодефицитной анемии препаратом Тотема в зависимости от этиологии. Вестник последипломного медицинского образования. 2014; 1: 74-5.
  32. Ковригина Е.С., Казанец Е.Г., Карамян Н.А., Айвазова Д.Х., Лукьянова Е.Г., Панфилова Е.Л. Современные методы диагностики железодефицитной анемии у беременных и критерии оценки эффективности ферротерапии. Гинекология. 2005; 7(2): 90-2.
  33. Стуклов Н.И. Мета-анализ данных переносимости питьевой формы глюконата железа (II), меди и марганца (препарат Тотема) при лечении железодефицитной анемии у детей и взрослых. Современная педиатрия. 2012; 7: 52-60.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies